Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17641-08-6

Post Buying Request

17641-08-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17641-08-6 Usage

Uses

2-Chloro-n-(3-methoxyphenyl)acetamide. Aripiprazole Impurity

Check Digit Verification of cas no

The CAS Registry Mumber 17641-08-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,6,4 and 1 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 17641-08:
(7*1)+(6*7)+(5*6)+(4*4)+(3*1)+(2*0)+(1*8)=106
106 % 10 = 6
So 17641-08-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H10ClNO2/c1-13-8-4-2-3-7(5-8)11-9(12)6-10/h2-5H,6H2,1H3,(H,11,12)

17641-08-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Chloro-N-(3-methoxyphenyl)acetamide

1.2 Other means of identification

Product number -
Other names m-ACETANISIDIDE,2-CHLORO

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17641-08-6 SDS

17641-08-6Synthetic route

Chloroiodomethane
593-71-5

Chloroiodomethane

3-methoxyphenyl isocyanate
18908-07-1

3-methoxyphenyl isocyanate

2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With methyllithium lithium bromide In diethyl ether at -78℃;94%
With methyllithium; lithium bromide In diethyl ether at -78℃; for 0.5h; chemoselective reaction;94%
m-Anisidine
536-90-3

m-Anisidine

chloroacetyl chloride
79-04-9

chloroacetyl chloride

2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
In tetrahydrofuran at 0 - 10℃; for 3h;92%
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 1h; Inert atmosphere;91.5%
With acetic acid at 20℃; for 1.5h; Cooling with ice;89%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

2-hydroxybromobenzene
95-56-7

2-hydroxybromobenzene

4-(3-methoxyphenyl)-2H-1,4-benzoxazin-3(4H)-one
1134193-44-4

4-(3-methoxyphenyl)-2H-1,4-benzoxazin-3(4H)-one

Conditions
ConditionsYield
With palladium diacetate; caesium carbonate; 2,2'-bis-(diphenylphosphino)-1,1'-binaphthyl In toluene at 110℃; for 24h; Inert atmosphere;91%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

C39H55NO5

C39H55NO5

Conditions
ConditionsYield
Stage #1: ursonic acid With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide With potassium iodide In N,N-dimethyl-formamide at 20℃; for 12h;
88.6%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

3-(3,4,5-trimethoxyphenyl)-4H-5-mercapto-1,2,4-triazole
14803-86-2

3-(3,4,5-trimethoxyphenyl)-4H-5-mercapto-1,2,4-triazole

N-(3-methoxy-phenyl)-2-(5-(3,4,5-trimethoxy-phenyl)-4H-1,2,4-triazol-3 ylsulfanyl)-acetamide

N-(3-methoxy-phenyl)-2-(5-(3,4,5-trimethoxy-phenyl)-4H-1,2,4-triazol-3 ylsulfanyl)-acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; Alkaline conditions;88%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

4-(4-hydroxybenzylidene)-1-(3-methoxyphenyl)-2-phenyl-1H-imidazol-5(4H)-one

4-(4-hydroxybenzylidene)-1-(3-methoxyphenyl)-2-phenyl-1H-imidazol-5(4H)-one

N-(3-methoxyphenyl)-2-(4-((1-(3-methoxyphenyl)-5-oxo-2-phenyl-1,5-dihydro-4H-imidazol-4-ylidene)methyl)phenoxy)acetamide

N-(3-methoxyphenyl)-2-(4-((1-(3-methoxyphenyl)-5-oxo-2-phenyl-1,5-dihydro-4H-imidazol-4-ylidene)methyl)phenoxy)acetamide

Conditions
ConditionsYield
Stage #1: 4-(4-hydroxybenzylidene)-1-(3-methoxyphenyl)-2-phenyl-1H-imidazol-5(4H)-one With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide In N,N-dimethyl-formamide at 100℃; for 8h;
87%
piperidine
110-89-4

piperidine

2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

N-(3-methoxy-phenyl)-2-piperidin-1-yl-acetamide
40297-47-0

N-(3-methoxy-phenyl)-2-piperidin-1-yl-acetamide

Conditions
ConditionsYield
In acetone for 2h; Heating;86%
With benzene
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

6-chloro-9-mercapto-2-methoxy-acridine
2411-88-3

6-chloro-9-mercapto-2-methoxy-acridine

2-(6-chloro-2-methoxyacridin-9-ylthio)-N-(3-methoxyphenyl)acetamide

2-(6-chloro-2-methoxyacridin-9-ylthio)-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetone for 3h; Reflux;86%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

potassium-2,4-dioxo-5-(pyridin-2-ylmethylene)thiazolidin-3-ide

potassium-2,4-dioxo-5-(pyridin-2-ylmethylene)thiazolidin-3-ide

2-(2,4-dioxo-5-(pyridin-2-ylmethylene)thiazolidin-3-yl)-N-(3-methoxyphenyl)acetamide

2-(2,4-dioxo-5-(pyridin-2-ylmethylene)thiazolidin-3-yl)-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
In methanol Reflux;85%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

4-tert-butyl-2-iodophenol
38941-98-9

4-tert-butyl-2-iodophenol

6-tert-butyl-4-(3-methoxyphenyl)-2H-1,4-benzoxazin-3(4H)-one
1134193-57-9

6-tert-butyl-4-(3-methoxyphenyl)-2H-1,4-benzoxazin-3(4H)-one

Conditions
ConditionsYield
With copper(l) iodide; caesium carbonate; 1,8-diazabicyclo[5.4.0]undec-7-ene In dimethyl sulfoxide at 130℃; for 0.166667h; Microwave irradiation;84%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

1,4-bis(3-methoxyphenyl)piperazine-2,5-dione
847240-15-7

1,4-bis(3-methoxyphenyl)piperazine-2,5-dione

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In water; acetone at 56℃; for 5h;83%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

2-methylimidazole
693-98-1

2-methylimidazole

N-(3-methoxyphenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamide
1378478-71-7

N-(3-methoxyphenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamide

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60 - 70℃;83%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

7(1H)-oxo-2-phenyl cyclopenta pyridine-6-carbonitrile
126921-96-8

7(1H)-oxo-2-phenyl cyclopenta pyridine-6-carbonitrile

2-[(4-cyano-1-phenyl-6,7-dihydro-5H-cyclopenta[c]pyridin-3-yl)oxy]-N-(3-methoxyphenyl)acetamide

2-[(4-cyano-1-phenyl-6,7-dihydro-5H-cyclopenta[c]pyridin-3-yl)oxy]-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 100℃; for 2h;83%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

1-(2-Furyl)-3-oxo-3,5,6,7-tetrahydro-2H-cyclopenta[c]pyridine-4-carbonitrile

1-(2-Furyl)-3-oxo-3,5,6,7-tetrahydro-2H-cyclopenta[c]pyridine-4-carbonitrile

2-{[4-cyano-1-(2-furyl)-6,7-dihydro-5H-cyclopenta[c]pyridin-3-yl]oxy}-N-(3-methoxyphenyl)acetamide

2-{[4-cyano-1-(2-furyl)-6,7-dihydro-5H-cyclopenta[c]pyridin-3-yl]oxy}-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 100℃; for 2h;82%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

1-phenyl-2,3,4,9-tetrahydro-1H-beta-carboline
3790-45-2, 121998-74-1, 142696-56-8, 148261-76-1

1-phenyl-2,3,4,9-tetrahydro-1H-beta-carboline

2-(3,4-dihydro-1-phenyl-1H-pyrido[3,4-b]indol-2(9H)-yl)-N-(3-methoxyphenyl)acetamide

2-(3,4-dihydro-1-phenyl-1H-pyrido[3,4-b]indol-2(9H)-yl)-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
Stage #1: 1-phenyl-2,3,4,9-tetrahydro-1H-beta-carboline With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide In N,N-dimethyl-formamide at 20℃; for 3h;
80%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

4-(5-amino-4-benzothiazol-2-yl-3-oxo-2,3-dihydro-pyrrol-1-yl)-benzoic acid
610278-84-7

4-(5-amino-4-benzothiazol-2-yl-3-oxo-2,3-dihydro-pyrrol-1-yl)-benzoic acid

4-(5-amino-4-benzothiazol-2-yl-3-oxo-2,3-dihydro-pyrrol-1-yl)-benzoic acid (3-methoxy-phenylcarbamoyl)-methyl ester

4-(5-amino-4-benzothiazol-2-yl-3-oxo-2,3-dihydro-pyrrol-1-yl)-benzoic acid (3-methoxy-phenylcarbamoyl)-methyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 110 - 120℃; for 3h;79%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

4-(prop-2-ynyloxy)benzaldehyde
5651-86-5

4-(prop-2-ynyloxy)benzaldehyde

C19H18N4O4

C19H18N4O4

Conditions
ConditionsYield
Stage #1: 2-chloro-N-(3-methoxyphenyl)acetamide With sodium azide; triethylamine In water; N,N-dimethyl-formamide for 3h; Reflux;
Stage #2: 4-(prop-2-ynyloxy)benzaldehyde With copper(ll) sulfate pentahydrate; sodium L-ascorbate In water; N,N-dimethyl-formamide for 24h; Reflux;
78.2%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

3-amino-2-phenylquinazolin-4(3H)-one
1904-60-5

3-amino-2-phenylquinazolin-4(3H)-one

N-(3-Methoxy-phenyl)-2-(4-oxo-2-phenyl-4H-quinazolin-3-ylamino)-acetamide

N-(3-Methoxy-phenyl)-2-(4-oxo-2-phenyl-4H-quinazolin-3-ylamino)-acetamide

Conditions
ConditionsYield
In methanol for 2h; Heating;78%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

(E)-4-ethoxy-3-(1-(hydroxyimino)ethyl)-2-methyl-2H-benzo[e][1,2]thiazine 1,1-dioxide
1580541-09-8

(E)-4-ethoxy-3-(1-(hydroxyimino)ethyl)-2-methyl-2H-benzo[e][1,2]thiazine 1,1-dioxide

(E)-2-(((1-(4-ethoxy-2-methyl-1,1-dioxido-2H-benzo[e][1,2]thiazin-3-yl)ethylidene)amino)oxy)-N-(3-methoxyphenyl)acetamide
1580541-13-4

(E)-2-(((1-(4-ethoxy-2-methyl-1,1-dioxido-2H-benzo[e][1,2]thiazin-3-yl)ethylidene)amino)oxy)-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
Stage #1: (E)-4-ethoxy-3-(1-(hydroxyimino)ethyl)-2-methyl-2H-benzo[e][1,2]thiazine 1,1-dioxide With potassium carbonate In N,N-dimethyl-formamide at 0℃; for 0.5h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide In N,N-dimethyl-formamide at 20℃;
78%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

2-Amino-5-mercapto-1,3,4-thiadiazole
2349-67-9

2-Amino-5-mercapto-1,3,4-thiadiazole

2-amino-5-[(3-methoxyphenylcarbamoyl)methylthio]-1,3,4-thiadiazole

2-amino-5-[(3-methoxyphenylcarbamoyl)methylthio]-1,3,4-thiadiazole

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 20℃;78%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

2-phenyl-10H-pyrimido<1,2-a>benzimidazol-4-one
50290-45-4

2-phenyl-10H-pyrimido<1,2-a>benzimidazol-4-one

2-(4-oxo-2-phenylpyrimido[1,2-a]benzimidazol-10(4H)-yl)-N-(3-methoxyphenyl)acetamide
1031620-28-6

2-(4-oxo-2-phenylpyrimido[1,2-a]benzimidazol-10(4H)-yl)-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90 - 100℃; regioselective reaction;77%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

ciprofloxacin
85721-33-1

ciprofloxacin

1-cyclopropyl-6-fluoro-7-(4-(2-(3-methoxyphenylamino)-2-oxoethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

1-cyclopropyl-6-fluoro-7-(4-(2-(3-methoxyphenylamino)-2-oxoethyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Conditions
ConditionsYield
With triethylamine; potassium iodide In N,N-dimethyl-formamide at 125℃; Inert atmosphere;77%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

2-cyanomethylbenzothiazole
56278-50-3

2-cyanomethylbenzothiazole

5-amino-4-(2-benzothiazolyl)-2,3-dihydro-1-(3-methoxyphenyl)-2-pyrrolone

5-amino-4-(2-benzothiazolyl)-2,3-dihydro-1-(3-methoxyphenyl)-2-pyrrolone

Conditions
ConditionsYield
With potassium carbonate In ethanol for 1h; Heating;76%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

(E)-4-hydroxy-3-(1-(hydroxyimino)ethyl)-2-methyl-2H-benzo[e][1,2]thiazine 1,1-dioxide
1580541-10-1

(E)-4-hydroxy-3-(1-(hydroxyimino)ethyl)-2-methyl-2H-benzo[e][1,2]thiazine 1,1-dioxide

(E)-2-(((1-(4-hydroxy-2-methyl-1,1-dioxido-2H-benzo[e][1,2]thiazin-3-yl)ethylidene)amino)oxy)-N-(3-methoxyphenyl)acetamide
1580541-21-4

(E)-2-(((1-(4-hydroxy-2-methyl-1,1-dioxido-2H-benzo[e][1,2]thiazin-3-yl)ethylidene)amino)oxy)-N-(3-methoxyphenyl)acetamide

Conditions
ConditionsYield
Stage #1: (E)-4-hydroxy-3-(1-(hydroxyimino)ethyl)-2-methyl-2H-benzo[e][1,2]thiazine 1,1-dioxide With potassium carbonate In N,N-dimethyl-formamide at 0℃; for 0.5h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide In N,N-dimethyl-formamide at 20℃;
76%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

4-Hydroxyquinazoline
491-36-1

4-Hydroxyquinazoline

N-(3-Methoxy-phenyl)-2-(4-oxo-4H-quinazolin-3-yl)-acetamide
108086-41-5

N-(3-Methoxy-phenyl)-2-(4-oxo-4H-quinazolin-3-yl)-acetamide

Conditions
ConditionsYield
With pyridine for 2h; Heating;75%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

3-{5-amino-4-[4-(4-chloro-phenyl)-thiazol-2-yl]-3-oxo-2,3-dihydro-pyrrol-1-yl}-benzoic acid
749216-03-3

3-{5-amino-4-[4-(4-chloro-phenyl)-thiazol-2-yl]-3-oxo-2,3-dihydro-pyrrol-1-yl}-benzoic acid

3-{5-amino-4-[4-(4-chloro-phenyl)-thiazol-2-yl]-3-oxo-2,3-dihydro-pyrrol-1-yl}-benzoic acid (3-methoxy-phenylcarbamoyl)-methyl ester

3-{5-amino-4-[4-(4-chloro-phenyl)-thiazol-2-yl]-3-oxo-2,3-dihydro-pyrrol-1-yl}-benzoic acid (3-methoxy-phenylcarbamoyl)-methyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 110 - 120℃; for 3h;75%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

2-(piperazin-1-yl)nicotinonitrile
84951-44-0

2-(piperazin-1-yl)nicotinonitrile

2-[4-(3-cyano-pyridin-2-yl)-piperazin-1-yl]-N-(3-methoxy-phenyl)-acetamide

2-[4-(3-cyano-pyridin-2-yl)-piperazin-1-yl]-N-(3-methoxy-phenyl)-acetamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In toluene at 80℃;75%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

4-(4-hydroxybenzylidene)-1-(4-methoxyphenyl)-2-phenyl-1H-imidazol-5(4H)-one

4-(4-hydroxybenzylidene)-1-(4-methoxyphenyl)-2-phenyl-1H-imidazol-5(4H)-one

N-(3-methoxyphenyl)-2-(4-((1-(4-methoxyphenyl)-5-oxo-2-phenyl-1,5-dihydro-4H-imidazol-4-ylidene)methyl)phenoxy)acetamide

N-(3-methoxyphenyl)-2-(4-((1-(4-methoxyphenyl)-5-oxo-2-phenyl-1,5-dihydro-4H-imidazol-4-ylidene)methyl)phenoxy)acetamide

Conditions
ConditionsYield
Stage #1: 4-(4-hydroxybenzylidene)-1-(4-methoxyphenyl)-2-phenyl-1H-imidazol-5(4H)-one With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide In N,N-dimethyl-formamide at 100℃; for 8h;
74%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

6-benzyl-2-thioxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-3-carbonitrile

6-benzyl-2-thioxo-1,2,5,6,7,8-hexahydro-1,6-naphthyridine-3-carbonitrile

3-amino-6-benzyl-N-(3'-methoxyphenyl)-5,6,7,8-tetrahydrothieno[2,3-b][1,6]naphthyridine-2-carboxamide

3-amino-6-benzyl-N-(3'-methoxyphenyl)-5,6,7,8-tetrahydrothieno[2,3-b][1,6]naphthyridine-2-carboxamide

Conditions
ConditionsYield
With sodium carbonate In ethanol Inert atmosphere; Reflux;74%
2-chloro-N-(3-methoxyphenyl)acetamide
17641-08-6

2-chloro-N-(3-methoxyphenyl)acetamide

3-(4-chloro-phenylimino)-1,3-dihydro-indol-2-one
57644-24-3

3-(4-chloro-phenylimino)-1,3-dihydro-indol-2-one

C23H18ClN3O3

C23H18ClN3O3

Conditions
ConditionsYield
Stage #1: 3-(4-chloro-phenylimino)-1,3-dihydro-indol-2-one With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: 2-chloro-N-(3-methoxyphenyl)acetamide With potassium iodide In N,N-dimethyl-formamide at 60℃; for 5.5h;
73%

17641-08-6Relevant articles and documents

An efficient, four-component reaction for the synthesis of novel carbamodithioates

Sadat-Ebrahimi, Seyed Esmail,Karim, Leila,Moghimi, Setareh,Yahya-Meymandi, Azadeh,Mahdavi, Mohammad,Vosooghi, Mohsen,Foroumadi, Alireza,Shafiee, Abbas

, p. 43 - 51 (2017)

A series of substituted phenylcarbamoyl methyl benzylcarbamodithioates have been synthesized using the multicomponent condition. The reaction proceeded under mild practical condition and afforded the desired products in good yields.

Anti-melanogenesis and anti-tyrosinase properties of aryl-substituted acetamides of phenoxy methyl triazole conjugated with thiosemicarbazide: Design, synthesis and biological evaluations

Hosseinpoor, Hona,Moghadam Farid, Sara,Iraji, Aida,Askari, Sadegh,Edraki, Najmeh,Hosseini, Samanesadat,Jamshidzadeh, Akram,Larijani, Bagher,Attarroshan, Mahshid,Pirhadi, Somayeh,Mahdavi, Mohammad,Khoshneviszadeh, Mehdi

, (2021/06/21)

A series of aryl phenoxy methyl triazole conjugated with thiosemicarbazides were designed, synthesized, and evaluated for their tyrosinase inhibitory activities in the presence of L-dopa and L-tyrosine as substrates. All the compounds showed tyrosinase inhibition in the sub-micromolar concentration. Among the derivatives, compound 9j bearing benzyl displayed exceptionally high potency against tyrosinase with IC50 value of 0.11 μM and 0.17 μM in the presence of L-tyrosine and L-dopa as substrates which is significantly lower than that of kojic acid as the positive control with an IC50 value of 9.28 μM for L-tyrosine and 9.30 μM for L-dopa. According to Lineweaver–Burk plot, 9j demonstrated an uncompetitive type of inhibition in the kinetic assay. Also, in vitro antioxidant activities determined by DPPH assay recorded an IC50 value of 68.43 μM for 9i. The melanin content of 9j was determined on B16F10 melanoma human cells which demonstrated a significant reduction of the melanin content. Moreover, the binding energies corresponding to the same ligand as well as computer-aided drug-likeness and pharmacokinetic studies were also carried out. Compound 9j also possessed metal chelation potential correlated to its high anti-TYR activity.

Synthesis, biological evaluation, and structure-activity relationships of new tubulin polymerization inhibitors based on 5-amino-1,2,4-triazole scaffold

Yang, Fang,Chen, Lin,Lai, Jin-Mei,Jian, Xie-Er,Lv, Dong-Xin,Yuan, Li-Li,Liu, Yu-Xia,Liang, Feng-Ting,Zheng, Xiao-Lan,Li, Xiong-Li,Wei, Li-Yuan,You, Wen-Wei,Zhao, Pei-Liang

, (2021/03/06)

Based on our previous research, thirty new 5-amino-1H-1,2,4-triazoles possessing 3,4,5-trimethoxyphenyl moiety were synthesized, and evaluated for antiproliferative activities. Among them, compounds IIa, IIIh, and IIIm demonstrated significant antiproliferative activities against a panel of tumor cell lines, and the promising compound IIIm dose-dependently caused G2/M phase arrest in HeLa cells. Furthermore, analogue IIa exhibited the most potent tubulin polymerization inhibitory activity with an IC50 value of 9.4 μM, and molecular modeling studies revealed that IIa formed stable interactions in the colchicine-binding site of tubulin, suggesting that 5-amino-1H-1,2,4-triazole scaffold has potential for further investigation to develop novel tubulin polymerization inhibitors with anticancer activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17641-08-6